Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells-Reference-Cited by-同舟云学术

Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells

Published:2013-10 Issue:1 Volume:149 Page:55-64
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Liu Daofeng,Song Liping,Brawley Vita S.,Robison Nathan,Wei Jie,Gao Xiuhua,Tian Gengwen,Margol Ashley,Ahmed Nabil,Asgharzadeh Shahab,Metelitsa Leonid S.

Funder

National Institutes of Health

Cancer Prevention and Research Institute of Texas

The Caroline Wiess Law Scholar Award (LSM)

American Brain Tumor Association and Alliance for Cancer Gene Therapy (NA)

American Cancer Society

Alex's Lemonade Stand Foundation

St. Baldrick's Foundation (SA)

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference37 articles.

1. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma;Packer;J. Clin. Oncol.,2006

2. The tumor biology and molecular characteristics of medulloblastoma identifying prognostic factors associated with survival outcomes and prognosis;Kim;J. Clin. Neurosci.,2011

3. Childhood medulloblastoma: the paradigm shift in molecular stratification and treatment profile;Sadighi;J. Child Neurol.,2012

4. The 2007 WHO classification of tumours of the central nervous system;Louis;Acta Neuropathol.,2007

5. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations;Thompson;J. Clin. Oncol.,2006

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles and interactions of tumor microenvironment components in medulloblastoma with implications for novel therapeutics;Genes, Chromosomes and Cancer;2024-04

2. Exploiting innate immunity for cancer immunotherapy;Molecular Cancer;2023-11-27

3. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing;Functional & Integrative Genomics;2023-08-31

4. A Personalized Cancer Vaccine that Induces Synergistic Innate and Adaptive Immune Responses;Advanced Materials;2023-07-21

5. The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors;Current Oncology;2023-05-25